The Royal Marsden Hospital treats the first UK patient on Elekta’s MR-linac
Published on: 25th September 2018
In 2012, Elekta engaged DCA Design International as the company’s design partner for its MR-linac system. DCA worked with Elekta to create a future vision for the industrial design and usability of Elekta’s MR-linac system. There are currently twelve research devices operational worldwide, and having received a CE mark earlier this year the system is now being implemented clinically in Europe, ushering in a transformation in precision and personalised cancer treatment.
Elekta Unity has CE mark but is not available for commercial distribution or sale in the U.S.